Cdk1 Phosphorylates SPAT-1/Bora to Promote Plk1 Activation in C. elegans and Human Cells  by Thomas, Yann et al.
ReportCdk1 Phosphorylates SPAT-1/Bora to Promote Plk1
Activation in C. elegans and Human CellsGraphical AbstractHighlightsd Conserved role for Cdk1-mediated SPAT-1/Bora
phosphorylation in Plk1 activation
d Binding of Cyclin B to Bora
d Identification of three conserved and functionally important
Bora phospho-sites
d Requirement of Bora phosphorylation for mitotic entry in
human cells after DNA damageThomas et al., 2016, Cell Reports 15, 510–518
April 19, 2016 ª2016 The Authors
http://dx.doi.org/10.1016/j.celrep.2016.03.049Authors
Yann Thomas, Luca Cirillo,
Costanza Panbianco, ...,
Anna Santamaria, Lionel Pintard,
Monica Gotta
Correspondence
lionel.pintard@ijm.fr (L.P.),
monica.gotta@unige.ch (M.G.)
In Brief
Thomas et al. now find that Cyclin B/Cdk1
phosphorylates SPAT-1/Bora to promote
Plk1 activation inC. elegans and in human
cells. They identify three conserved
phosphorylation sites in SPAT-1 and Bora
that promote timely mitotic entry in the
embryo and G2-checkpoint recovery
from DNA damage in human cells.
Cell Reports
ReportCdk1 Phosphorylates SPAT-1/Bora to Promote
Plk1 Activation in C. elegans and Human Cells
Yann Thomas,1,5 Luca Cirillo,2,5 Costanza Panbianco,2 Lisa Martino,1 Nicolas Tavernier,1 Franc¸oise Schwager,2
Lucie Van Hove,1 Nicolas Joly,1 Anna Santamaria,4 Lionel Pintard,1,6,* and Monica Gotta2,3,6,*
1Jacques Monod Institute, UMR7592, Paris-Diderot University, Centre National de la Recherche Scientifique, 75013 Paris, France
2Department of Cellular Physiology and Metabolism, Faculty of Medicine, University of Geneva, 1211 Geneva 4, Switzerland
3Swiss National Centre for Competence in Research Program Chemical Biology, 1211 Geneva, Switzerland
4Cell Cycle and Ovarian Cancer Group, Biomedical Research Unit in Gynecology, Collserola Building, Vall Hebron Research Institute,
08035 Barcelona, Spain
5Co-first author
6Co-senior author
*Correspondence: lionel.pintard@ijm.fr (L.P.), monica.gotta@unige.ch (M.G.)
http://dx.doi.org/10.1016/j.celrep.2016.03.049SUMMARY
TheconservedBoraprotein is aPlk1activator, essen-
tial for checkpoint recovery after DNA damage in
human cells. Here, we show that Bora interacts with
Cyclin B and is phosphorylated by Cyclin B/Cdk1 at
several sites. The first 225 amino acids of Bora, which
contain two Cyclin binding sites and three conserved
phosphorylated residues, are sufficient to promote
Plk1 phosphorylation by Aurora A in vitro. Mutating
the Cyclin binding sites or the three conserved phos-
phorylation sites abrogates the ability of the N termi-
nus of Bora to promote Plk1 activation. In human
cells, Bora-carryingmutations of the three conserved
phosphorylation sites cannot sustainmitotic entry af-
ter DNA damage. In C. elegans embryos, mutation of
the three conserved phosphorylation sites in SPAT-1,
the Bora ortholog, results in a severe mitotic entry
delay. Our results reveal a crucial and conserved
role of phosphorylation of the N terminus of Bora for
Plk1 activation and mitotic entry.INTRODUCTION
Polo-like kinase 1 (Plk1) plays a pivotal role in cell division by
controlling multiple processes including centrosomematuration,
spindle assembly, chromosome segregation, and cytokinesis
(Archambault and Glover, 2009). Plk1 is also essential for the
development of multicellular organisms; for instance, it regulates
polarity in sensory organ precursors (SOPs) and epithelial cells in
flies (Shrestha et al., 2015; Wang et al., 2007) and coordinates
polarity, cell fate, and the asynchrony of cell division in the early
C. elegans embryo (Nishi et al., 2008; Budirahardja and Go¨nczy,
2008; Rivers et al., 2008; Noatynska et al., 2013).
After DNA damage, Plk1 is essential for G2-checkpoint recov-
ery (van Vugt et al., 2004). The kinases ATM (ataxia telengectasia
mutated) and ATR (ataxia telengectasia mutated and Rad3-510 Cell Reports 15, 510–518, April 19, 2016 ª2016 The Authors
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strates to promote checkpoint activation and DNA repair.
Upon completion of DNA repair, the cell inactivates the check-
point and resumes cell-cycle progression in a process termed
‘‘G2-checkpoint recovery’’ in which Plk1 plays a dual role: it
inhibits checkpoint components and promotes progression
through mitosis (Mailand et al., 2006; Mamely et al., 2006; van
Vugt et al., 2010; van Vugt and Yaffe, 2010).
Plk1 is characterized by an N-terminal kinase domain and a
C-terminal non-catalytic region containing two tandem Polo
boxes (Polo box domain [PBD]; Cheng et al., 2003). Spatial con-
trol of Plk1 function ismediated by the conserved PBD (Lee et al.,
1998), which recognizes peptides previously phosphorylated by
other kinases (Elia et al., 2003).
Plk1 kinase activity depends on its phosphorylation on a
conserved threonine (Thr) residue (T210) located in the T-loop
of the kinase domain (Jang et al., 2002). This phosphorylation
is mediated by the Aurora A kinase during both a normal mitosis
(Seki et al., 2008b) and checkpoint recovery from DNA damage
(Macurek et al., 2008). The efficiency of this phosphorylation
requires Bora, originally identified in Drosophila melanogaster
(Hutterer et al., 2006). In human cells, Bora binds Plk1 and
enhances Aurora A mediated T-loop phosphorylation of Plk1
(Seki et al., 2008b; Macurek et al., 2008).
Bora is phosphorylated by several kinases. Upon DNA dam-
age, ATR phosphorylates Bora to target it for degradation,
contributing to Plk1 inactivation and cell-cycle arrest (Qin et al.,
2013). Bora is also phosphorylated by other kinases including
Cdk1 (Hutterer et al., 2006; Chan et al., 2008; Feine et al.,
2014), Gsk3 (Lee et al., 2013), and Plk1 itself (Chan et al.,
2008; Seki et al., 2008a). Once mitosis starts, both Cdk1 and
Plk1 target Bora to proteolysis (Seki et al., 2008a; Chan et al.,
2008). However, a fraction of Bora escapes degradation and is
required to sustain Plk1 activity during mitosis (Bruinsma et al.,
2014). Hyperphosphorylated Bora accumulates at the G2-M
transition and co-precipitates with Plk1 (Seki et al., 2008b;
Chan et al., 2008).
The C. elegans ortholog of Bora, SPAT-1 (suppressor of Par-
two 1) (Labbe´ et al., 2006), also functions as a PLK-1 activatorcommons.org/licenses/by/4.0/).
(Noatynska et al., 2010). Loss of spat-1 or plk-1 delays mitotic
entry in early embryos. SPAT-1 is phosphorylated at multiple
sites by Cdk1, and phosphorylation is essential for its function,
although the exact sites crucial for the regulation of cell division
timing have not been identified yet (Tavernier et al., 2015).
Here, we show that Cdk1 phosphorylates Bora on multiple
serine (Ser) and Thr residues but that phosphorylation of three
conserved residues located in the N-terminal part of the protein
promotes activation of Plk1 in vitro and is essential for mitotic
entry after DNA damage in vivo. Moreover, we demonstrate
that this pathway is conserved between worms and humans.
RESULTS
Cyclin B/Cdk1 Phosphorylates Bora at Multiple SP/TP
Sites In Vitro and In Vivo
Pre-phosphorylating Bora with Cyclin B/Cdk1 stimulates phos-
phorylation of Plk1 by Aurora A on its T-loop in vitro (Tavernier
et al., 2015). To further investigate the role of Cdk1-dependent
Bora phosphorylation for Plk1 activation, we used liquid chroma-
tography-tandemmass spectrometry (LC-MS/MS) tomapCdk1-
dependent Bora phosphorylation sites in vitro (as described in
Figures 1A and 1B). Fourteen SP/TP sites were identified, distrib-
uted along the entire protein (Figures 1F and S1B).
We then investigated whether these sites were also phosphor-
ylated in vivo. Indeed, it has been shown that Bora is maximally
phosphorylated in G2 in HeLa cells (Seki et al., 2008b; Chan
et al., 2008) when Plk1 and Cdk1 become activated. We gener-
ated a stable HEK293 cell line expressing Bora tagged with the
FLAG epitope (Figure S1A). We synchronized cells using a dou-
ble thymidine block and release protocol and found that Bora
phosphorylation is maximum 4 hr after release from the thymi-
dine block (Figure 1C). LC-MS/MS analysis of FLAG-Bora
immunoprecipitates at this time point (Figure 1D) led to the iden-
tification of 12 phosphorylated Ser and Thr followed by proline on
Bora, 10 of which were also identified in vitro (Figures 1F, S1B,
and S1E; Table S1).
Analysis of Bora interaction partners confirmed the presence of
not only Plk1 (Macurek et al., 2008; Seki et al., 2008b; Chan et al.,
2008) but alsoCyclinB1 (Figures 1EandS1D). BothCyclinB/Cdk1
andCyclin A/Cdk1 are active at 4 hr (FigureS1C), but Cyclin Awas
not recovered in FLAG-Bora immunoprecipitates. Although we
cannot exclude a contribution of Cyclin A/Cdk1 in these cells or
in somatic cells, our data suggest that Cyclin B/Cdk1 is the major
kinase phosphorylating Bora. In conclusion, Bora is phosphory-
lated at multiple SP/TP Cdk1 consensus sites.
An N-Terminal Fragment of Bora Containing the First
225 Amino Acids Supports Cdk1-Dependent Plk1
Activation In Vitro
To find which sites are critical for Plk1 activation, we set to iden-
tify the minimal fragment of Bora supporting Cdk1-dependent
Plk1 activation in vitro. We used a previously described assay
that monitors the activity of Aurora A toward Plk1 in the presence
of Bora phosphorylated byCyclin B/Cdk1 (Tavernier et al., 2015).
Briefly, Bora is first phosphorylated by Cyclin B/Cdk1 (step 1)
and then incubated with purified Plk1 and Aurora A in the pres-
ence of ATP (Figure 2A). The first readout is the phosphorylationof Plk1 at residue T210, an indicator of Plk1 activity (Step 2). The
second read-out is the hyperphosphorylation of Bora resulting
from Plk1 activation, which leads to a higher mobility shift on
SDS-PAGE (step 2) than the one due to Cdk1-dependent phos-
phorylation alone (step 1; Figure 2A).
We tested Bora fragments lacking the C-terminal part, which is
the less conserved part of the protein. We produced these frag-
ments in bacteria fused to MBP (maltose-binding protein) or to
the 6x(His) tag and obtained identical results (Figures 2A and
S2). Using this assay, we found that a Bora fragment containing
the first 225 amino acids can promote Plk1 activation in vitro, as
revealed by the appearance of Plk1 T210 phosphorylation and
the mobility shift of Bora 1-225 (Figures 2A and S2). Therefore,
the N-terminal conserved fragment of Bora is sufficient to
support Plk1 activation by Aurora A in vitro, and this depends
on previous phosphorylation by Cdk1.
Three Conserved Phosphorylation Sites in Bora Are
Critical for Plk1 Activation In Vitro
Phosphorylation of SPAT-1, theC. elegans ortholog of Bora, pro-
motes PLK-1 activation and mitotic entry in early embryos (Tav-
ernier et al., 2015). The critical Ser and Thr residues are located in
the N-terminal half of SPAT-1, suggesting that, in both human
cells andworms, the N-terminal part of the protein plays a crucial
role in Plk1 activation. We therefore performed multiple protein
sequence alignments of Bora and SPAT-1 from different species
and found two interesting features (Figure 2B).
First, we identified two Cyclin-binding sites (Cy or RXL; Adams
et al., 1996; Chen et al., 1996) in the N-terminal part of both
SPAT-1 and Bora. One of these sites, S-L/T-R-R-K/R-L-F, is
well conserved between Bora and SPAT-1 (Figure 2B), whereas
the second motif is less conserved (PVGKKLTI for Bora and
LDLKKLG for SPAT-1; data not shown). The presence of Cy
motifs in the N-terminal part of Bora is consistent with our find-
ings that Cyclin B/Cdk1 efficiently phosphorylates these pro-
teins and that Cyclin B specifically co-immunoprecipitated with
FLAG-Bora (Figure 1C). Second, we found that three phosphor-
ylated residues are well conserved among species (Figure 2B),
suggesting that these residues may play a critical role for the
function of Bora and SPAT-1.
We therefore asked whether the Cy motifs and these three
conserved phosphorylation sites are important, in vitro, for the
ability of Bora to promote activation of Plk1. Mutating the Cymo-
tifs drastically reduced Bora phosphorylation by Cyclin B/Cdk1
in vitro (Figure S3A) and abrogated Bora binding to Cyclin B
in vivo, as revealed by co-immunoprecipitation experiments (Fig-
ure S3B), indicating that these Cy motifs are functional. Bora
1-225 mutated on the Cy motifs failed to support Cdk1-depen-
dent Plk1 activation in vitro (Figures 2C and S2). Likewise,
Bora 1-225 mutated on the three conserved phosphorylation
sites (S41A, S112A, and S137A) was inactive in vitro (Figure 2C).
Therefore, phosphorylation of Bora by Cyclin B/Cdk1 on three
conserved sites is critical for Plk1 activation in vitro.
Phosphorylation of Three Conserved Residues Is
Important for Bora Function in Human Cells
We next asked whether phosphorylation of the three conserved
residues is important for the function of Bora in human cells.Cell Reports 15, 510–518, April 19, 2016 511
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Figure 1. Cyclin B/Cdk1 Phosphorylates Bora on Multiple SP/TP In Vitro and In Vivo
(A) Flow chart of the approach used tomap Bora phosphorylation sites in vitro. Strep-Bora was purified from insect Sf9 cells using Strep-Tactin Sepharose beads
(1). Immobilized Strep-Bora was dephosphorylated with lambda phosphatase (2) and incubated with Cyclin B/Cdk1 in the presence of ATP (3).
(B) Western blot analysis of the purification (1), dephosphorylation (2), and phosphorylation with Cyclin B/Cdk1 (3) as summarized in (A). The western blot was
probed with a Strep/horseradish peroxidase antibody.
(C) Western blot analysis of FLAG-Bora immunoprecipitates from HEK293 cells. Antibodies used to probe the western blot are indicated on the right. HEK293
cells were synchronized by a double thymidine block, cells were collected at different time points after release, and cell extracts were prepared for FLAG
immunoprecipitation (time is indicated in hours at the top; AS, asynchronous). The slowly migrating bands of Bora observed with FLAG antibody correspond to
phosphorylated forms of the protein.
(D) Flow chart of the approach used to map Bora phosphorylation sites in vivo.
(E) Western blot analyses of control or FLAG immunoprecipitates (IP) of FLAG-Bora-expressing HEK293 cells 4 hr after release from the thymidine block using
FLAG (top) and Cyclin B1 (bottom) antibodies. 30 mg of the total extracts (input) was loaded for comparison.
(F) Schematic sequence of Bora with the positions of each phospho-residues identified in the different experimental settings.
See also Figure S1 and Table S1.Although Plk1 is not strictly required for G2-M transition, Plk1
and Bora are crucial for G2-checkpoint recovery from DNA dam-
age (van Vugt et al., 2004; Macurek et al., 2008; Figures 3A
and 3B).
We thus investigated the role of Bora phosphorylation during
this transition using an assay described in Figure 3A. We
induced DNA damage using Doxorubicin, triggering G2 arrest.512 Cell Reports 15, 510–518, April 19, 2016We then forced G2-arrested cells to enter mitosis with caffeine
and arrested them again in prometaphase using nocoda-
zole. We then measured the mitotic index using an antibody
against pS10-histone H3. Consistent with previous findings
(Macurek et al., 2008), depletion of Bora, or chemical inhibition
of Plk1, abrogated recovery from the arrest (Figures 3B, 3C,
and 3E).
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Figure 3. Phosphorylation of Three Con-
served Residues Is Essential for Bora
Function in Recovery from DNA Damage
Checkpoint in Human Cells
(A) Flow chart of the assay used in (B)–(F) to
assess the G2-checkpoint recovery from DNA
damage in HeLa K cells.
(B) Histogram showing the cumulative mitotic in-
dex of HeLa K cells transfected with control siRNA
or siRNA targeting Bora. Where indicated, cells
were treated with 100 nM BI2536 (the experiment
was repeated three times).
(C) Histogram showing the cumulative mitotic
index of HeLa cells control or Bora-depleted,
untreated (first and fourth column), treated with
doxorubicin (second and fifth column) or treated
with doxorubicin and caffeine (third and sixth
column) (the experiment was repeated four times).
(D) Histogram showing the cumulative mitotic
index (M.I.) after G2-checkpoint recovery of
control or Bora-depleted cells transfected with
different GFP-BoraR constructs (the experiment
was repeated three times).
For the histograms, mean ± SD is shown. Statis-
tical significance was determined using Student’s
t test: ns, p > 0.05, *p < 0.05, **p < 0.01, and ***p <
0.001.
(E) Western blot of HeLa K cells lysates after G2-
checkpoint recovery. The membrane was blotted
using an anti-pSerine10 Histone3 antibody (bot-
tom) and an anti-PCNA antibody (top).
(F) Western blot of HeLa K cell lysates (20 mg, left)
and GFP-Bora immunoprecipitates from HeLa
K cell lysates (right). The membrane was blotted
using an anti-Bora antibody (top) an anti-pT210-
Plk1 antibody (middle). The middle panel was
stripped and blotted with anti-Plk1 antibody
(bottom).
See also Figure S4.Next, we depleted Bora in HeLa cells previously transfected
with small interfering RNA (siRNA)-resistant versions of Bora
wild-type (GFP-BoraR) or mutated on the three conserved
phosphorylation sites (GFP-BoraRS41A,S112A,S137A, hereafter
GFP-BoraR3A) (Figures 3D, 3F, and S4). GFP-BoraR rescued
the checkpoint recovery defect caused by Bora depletion,
whereas GFP-BoraR3A showed a mitotic index similar to the
one caused by Bora depletion alone, indicating that BoraR3A
is not functional in promoting checkpoint recovery (Figure 3D).
These results are consistent with our observation that the
Bora fragment mutated on the three conserved sites isFigure 2. Three Conserved Phosphorylation Sites in Bora Are Critical f
(A) Left: flow chart of the assay used to test the role of Bora truncated versions in P
kinase assay of Plk1 with Aurora A (step 2) in the presence of 6x(His) Bora 1-225 fr
blots were probed with the indicated antibodies (right).
(B) Protein sequence alignments of human Bora, C. elegans SPAT-1, and other ho
the degree of amino acid conservation (from blue, low to red, high). The highly con
Cyclin-binding motifs are pictured with the same color code. The gray box indica
conserved phosphorylation sites and the Cyclin B binding site and surrounding s
(C) Western blot of the kinase assay of Plk1 with Aurora A, as described in (A). The
with both Cyclin binding motifs mutated (Cy) or mutated on the three conserved
See also Figures S2 and S3.
514 Cell Reports 15, 510–518, April 19, 2016unable to support Cdk1-dependent Plk1 activation in vitro
(Figure 2C).
We then monitored Plk1 T210 phosphorylation upon expres-
sion of BoraR or BoraR3A in human cells. Plk1 T210 phosphoryla-
tion was decreased in cells expressing the BoraR3A transgene
when compared to BoraR (Figure 3F, left). Furthermore, the
amount of total and active Plk1 co-immunoprecipitating with
BoraR3A was reduced as compared to BoraR, suggesting that
Bora phosphorylation on these three sites promotes Bora bind-
ing to Plk1 and activation (Figure 3F, right). This observation
is consistent with our previous findings in C. elegans thator Plk1 Activation In Vitro
lk1 phosphorylation by Aurora A. Right: western blot showing the results of the
agment previously (step 1) phosphorylated (+) or not () by Cyclin B/Cdk1. The
mologs from different species presented by color code, which corresponds to
served sequences corresponding the Ser 41, Ser 112, Ser 137, and one of the
tes the fragment 1–225 of human Bora. The amino acid alignment of the three
equences is shown below.
kinase assay was performed in the presence of 6x(His)-Bora 1–225 wild-type,
Ser residues (3A), phosphorylated (+) or not () by Cyclin B/Cdk1.
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Figure 4. SPAT-1 Phosphorylation on Three Conserved Sites Is Essential to Promote Timely Mitotic Entry in the Embryo
(A) Boxplot showing the mean elapsed time between ingression of cytokinesis furrow in P0 and NEBD in AB (left) or P1 (right) was determined and plotted in
embryos depleted of endogenous SPAT-1 expressing either wild-type (0A) or GFP::SPAT-1R mutated transgenes (shown at the top). For both panels, error bars
indicate 95% confidence limits. Statistical significance was determined using Student’s t test: *p < 0.05, **p < 0.01, ***p < 0.001, and ****p < 0.0001.
(B) Western blot analysis of embryos expressing GFP::SPAT-1R transgenes.
(C) Western blot analysis of Sf9 insect cell extracts infected for 72 hr with baculoviruses expressing PLK-1, AIR-1, and wild-type and mutant SPAT-1 proteins.
See also Table S2.phosphorylation of SPAT-1 is important for the interaction with
PLK-1 (Tavernier et al., 2015).
We conclude that the three conserved phosphorylation sites
are important for the function of Bora in promoting Plk1 activa-
tion and recovery from the DNA damage checkpoint in human
cells.
SPAT-1 Phosphorylation on Three Conserved Sites Is
Essential to Promote Timely Mitotic Entry in the Embryo
We next asked whether these three sites are crucial for the
C. elegans ortholog SPAT-1 to regulate mitotic entry timing in
the embryo. The first division of the embryo generates two blas-
tomeres, AB and P1, different in size, fate, and cell-cycle timing.
The cell-cycle length of AB and P1 is highly reproducible and can
bemonitored using differential interference contrast (DIC) micro-
scopy by measuring the elapsed time between the first and the
second division. Inactivation of SPAT-1 or PLK-1 delays mitotic
entry in both AB and P1 (Budirahardja and Go¨nczy, 2008; Riverset al., 2008; Noatynska et al., 2010). Cdk1 phosphorylates 13
sites on SPAT-1 in vitro, and a transgene with these sites
mutated to alanine is not able to rescue the cell division delay
caused by depletion of endogenous SPAT-1 (Tavernier et al.,
2015). We previously found that SPAT-1-depleted C. elegans
embryos expressing an S119A or S190A SPAT-1 transgene are
delayed in mitotic entry, both in AB and P1. We were however
unable to test the contribution of the third, conserved phos-
phorylation site (T229) (Tavernier et al., 2015). Here, we found
that embryos expressing a SPAT-1 transgene mutated at T229
(corresponding to S137 in Bora) were also delayed in mitotic
entry (Figures 4A and 4B). Embryos expressing SPAT-1 mutated
simultaneously on all three residues (S119A, S190A, and T229A)
were severely delayed in mitotic entry and displayed a cell-cycle
length similar to embryos expressing SPAT-1 mutated on the 13
phosphorylation sites or on the Cymotifs (Figures 4A and 4B; Ta-
ble S2; Tavernier et al., 2015), suggesting that these SPAT-1 mu-
tants are defective in PLK-1 activation.Cell Reports 15, 510–518, April 19, 2016 515
Accordingly, a SPAT-1 version mutated on the three con-
served sites failed to promote PLK-1 phosphorylation by AIR-1
(C. elegans ortholog of Aurora A) when the three proteins were
co-expressed in insect Sf9 cells (Figure 4C).
These data show that the three conserved Cdk1-dependent
sites in SPAT-1 are required for PLK-1 activation and regulation
of cell division timing in C. elegans embryos.
DISCUSSION
Plk1 plays a pivotal role in multiple cell division processes.
Plk1 is activated by the conserved protein Bora, which facili-
tates Plk1 phosphorylation by the Aurora A kinase on its acti-
vation loop (Macurek et al., 2008; Seki et al., 2008b). The
exact mechanism by which Bora activates Plk1 is incom-
pletely understood, but it is possible that Bora promotes
structural rearrangement of Plk1, exposing its activation loop
to Aurora A (Xu et al., 2013). Alternatively, Bora may activate
Aurora A to specifically phosphorylate Plk1 at T210. Here,
we reveal that the N-terminal 225 amino acids of Bora
(Bora-NT) are sufficient for Plk1 activation in vitro and that
phosphorylation on three conserved residues of this frag-
ment by Cyclin B/Cdk1 is essential for its function as Plk1 acti-
vator. Interestingly, this fragment of Bora does not contain the
Polo docking site (S252) (Chan et al., 2008), which is
consistent with the data in C. elegans where mutations of
the Polo docking site did not impair SPAT-1 function (Taver-
nier et al., 2015). Phosphorylation of the three conserved resi-
dues in SPAT-1 is also required for C. elegans PLK-1 activa-
tion in vitro. These sites are crucial for Bora and SPAT-1
function in vivo, in human cells to promote mitotic entry after
DNA damage, and in C. elegans to regulate the timing of em-
bryonic divisions.
What is the role of these three conserved phosphorylation
sites? SPAT-1 and Bora appear to lack a well-structured three-
dimensional fold. Intrinsically disordered regions or proteins
fold upon binding to their target in a process known as ‘‘coupled
folding and binding’’ (Wright and Dyson, 2015). The three phos-
phorylation sites are located in close proximity to each other,
within less than 100 amino acids. Phosphorylation of them may
promote folding and binding of Bora to Plk1, consistent with
our finding that GFP- BoraR3A co-immunoprecipitates less total
Plk1.
Further structural analysis of the minimal Bora fragment,
phosphorylated by Cyclin B/Cdk1 and in complex with Plk1
and Aurora A, will be required to elucidate the real function of
Bora and its phosphorylation in the binding to Plk1 and its
activation.
Besides the three conserved sites, Cyclin B/Cdk1 phosphory-
lates Bora and SPAT-1 at many other sites. Whereas phosphor-
ylation on T52 is known to block Bora degradation (Feine et al.,
2014), the contribution of the other sites to Bora function is yet
unknown. As we discussed previously (Tavernier et al., 2015),
these sites could buffer the activity of the Cyclin B/Cdk1 kinase,
making Plk1 activation by Cdk1 ultrasensitive similar to what has
been shown for Wee1 (Kim and Ferrell, 2007).
Our data indicate that Cdk1 is an activator of Plk1 during
checkpoint recovery, suggesting the existence of a feedback516 Cell Reports 15, 510–518, April 19, 2016loop involving Bora phosphorylation. What can be the trigger
of this putative feedback loop? Activation of the DNA damage
checkpoint must result in inhibition of Cdk1 to prevent cell-
cycle progression. However, low levels of active Cdk1 are
kept during DNA damage arrest and are required for the activ-
ity of the Forkhead transcription factor FoxM1 (Alvarez-Fer-
na´ndez et al., 2010), which is essential for the expression of
G2-specific genes including plk1, cyclin b, and bora (Wang
et al., 2005). Cdk1 activity is thus required to maintain expres-
sion of mitotic inducers during DNA damage, which then
engage in positive feedback loop during recovery, with Cdk1
activating Plk1 via Bora phosphorylation and, conversely,
Plk1 reinforcing Cdk1 activation via Cdc25 activation and
Wee1 inhibition.
Given the central role of Plk1 in G2-checkpoint recovery after
DNA damage, it is not surprising to observe Plk1 overexpression
in many cancers in correlation with more aggressiveness and
poor prognosis (Eckerdt et al., 2005). Elucidating the mecha-
nisms underlying Plk1 activation is of critical importance for the
understanding of cancer progression and for the development
of new therapeutic approaches.
EXPERIMENTAL PROCEDURES
Plasmid Construction and Antibodies
All plasmids used in this study and their construction is described in Sup-
plemental Information and in Table S3. Antibodies used in this study are
described Supplemental Experimental Procedures.
Cell Culture Methods and G2 DNA Damage Checkpoint Assay
HEK293 and HeLa Kyoto (HeLa K) cells were grown in DMEM (Gibco) supple-
mentedwith 10% fetal bovine serum (FBS;Gibco), 2mML-glutamine, 100U/ml
penicillin, and 100 mg/ml streptomycin (Invitrogen).
Transient DNA expression in HeLa K was performed using X-tremeGene 9
according to the manufacturer’s instructions (Roche). Stably transfected
HEK293 cells expressing FLAG-tagged Bora were generated using the
pMX-pie-pDest vector as described previously (Olma et al., 2009). The cells
were selected in complete DMEM supplemented with 1 mg/ml puromycin.
HeLa K cells were transfected with a previously validated siRNA targeting
endogenous Bora with the following sequence: 50-UAACUAGUCCUUCGC
CUAUUUdTdT-30 (Dharmacon, (Chan et al., 2008)). A scramble siRNA with
the sequence 50-GGACCUGGAGGUCUGCUGUdTdT-30 (QIAGEN) was used
as control. siRNA transfection of HeLa K was carried out using Lipofectamine
RNAiMAX transfection reagent according to the manufacturer’s instructions
(Invitrogen).
HEK293 cells were synchronized at the G1/S boundary by a double thymi-
dine block. Briefly, after treatment for 24 hr with 2.5 mM thymidine, the cells
were washed three times with serum-free DMEM and released into fresh com-
plete DMEM for 12 hr. Then the cells were treated again with 2.5 mM thymidine
for 24 hr. After three washes, the cells were released into fresh medium, after
which samples were taken at regular intervals for subsequent analysis.
Spodoptera frugiperda (Sf9) cells were grown a 27C in Insect-X press
(Lonza) supplemented with 2 mM L-glutamine.
For the G2-checkpoint recovery assay, HeLa K cells were transfected
with the different Bora constructs. The cells were then transfected with
the siRNA targeting endogenous Bora. DNA damage was induced by treat-
ing the cells with 100 nM doxorubicin (Sigma) for 1 hr; the culture me-
dium was then replaced with fresh DMEM containing 5 mM caffeine and
100 ng/ml nocodazole (both from Sigma). The latter medium was supple-
mented with an additional 100 nM BI2536 (Selleckchem) when indicated.
After 9-hr incubation, cells were fixed with cold 100% methanol, stained
with pS10-H3 antibody (Abcam), counterstained with DAPI, and counted
under the microscope.
Biochemical Assays
Phosphatase Treatment
Immobilized Strep-Bora was dephosphorylated by incubation with 800 U
lambda phosphatase for 2.5 hr at 30C in phosphatase buffer supplemented
with MnCl2.
Kinase Assays
Cyclin B/Cdk1 kinase assays were performed in 50 mM HEPES (pH 7.6),
10 mM MgCl2, 1 mM DTT, and protease and phosphatase inhibitor cocktails
with 5 U H.s Cyclin B/Cdk1 (New England Biolabs) in a final volume of 15 ml
containing 500–1,000 ng His-Bora, Strep-Bora, or Strep-SPAT-1 immobilized
on Strep-Tactin Sepharose beads. Reactions were initiated by adding a mix of
0.2 mM ATP and 5 mCi g-[32P]ATP) during 30 min at 30C.
For Aurora A-dependent kinase assays, 200–300 ng 6x(His)-Bora previously
phosphorylated or not by Cyclin B/Cdk1 was incubated in 50 mM Tris (pH 7.5),
15 mMMgCl2, 2 mM EGTA, 1 mM DTT, and protease and phosphatase inhib-
itor cocktails in the presence of 120 ng 6x(His)-Plk1 (Millipore) and 120 ng
6x(His)-Aurora A (Invitrogen). Reactions were initiated by adding a mix of
0.2 mM ATP for 30 min at 30C.
Immunoprecipitation and Western Blotting
Whole-cell extracts were prepared from mammalian cells by lysis in 50 mM
Tris-HCl (pH 7.4), 150 mM NaCl, 1 mM EDTA, 1 mM EGTA, 0.27 M sucrose,
1% Triton X-100, complete protease inhibitor cocktails, and phosphatase in-
hibitor PhosSTOP (Roche) for 30 min on ice before clarification by centrifuga-
tion. FLAG-tagged proteins were isolated by immunoprecipitation from 1 to
2 mg cell lysate using 10 ml M2-FLAG beads (Sigma) for 2 hr at 4C. All immu-
noprecipitations were washed in lysis buffer to remove nonspecific binding
before elution by boiling in Laemmli sample buffer. To detect protein in cell ly-
sates, protein samples were separated by SDS-PAGE and transferred onto
nitrocellulose. Proteins were detected by immunoblotting and visualized by
treating the blots with ECL (Millipore).
For Figures 3E and S4, HeLa K cells were lysed using the following pro-
tocol: Cells were washed with PBS and then lysed in a solution of 150 mM
Tris-HCl (pH 7.5), 5% SDS, and 25% glycerol warmed to 95C and scraped
from the well. The samples were then boiled for 5 min, sonicated, and
centrifuged. The supernatant was used to perform SDS-PAGE followed by
western blot as described above. For Figure 3F, HeLa K cells were lysed
in lysis buffer composed of 50 mM Tris-HCl (pH 7.5), 150 mM KCl, 5 mM
MgCl2, 5% glycerol, 1% Triton X-100, 2 mM 2-mercaptoethanol, PhosSTOP
phosphatase inhibitor (Roche), and complete protease inhibitor (Roche).
GFP-tagged proteins were isolated by immunoprecipitation of 3 mg lysate
using 15 ml GFP-Trap beads (Chromotek) for 2 hr at 4C. After immunopre-
cipitation, beads were washed with lysis buffer and resuspended in Laemmli
buffer. Proteins were then separated by SDS-PAGE and used for western
blot.
Protein extracts of C. elegans embryos and western blot analysis were per-
formed as described elsewhere (Tavernier et al., 2015).
Nematode Experiments and Microscopy
Nematode strains, culture conditions, and RNAi are described in the Supple-
mental Experimental Procedures.
Cell-cycle length measurement in C. elegans early embryos was performed
as described in Tavernier et al. (2015). For time-lapse imaging, early embryos
were extracted from gravid worms in egg buffer (118 mM NaCl, 48 mM KCl,
2 mM CaCl2, 2 mM MgCl2, and 25 mM HEPES [pH 7.3]) and mounted on a
2% agarose pad. A Leica DM6000 microscope (Leica Microsystems) equip-
ped with epifluorescence and DIC optics and a DFC 360 FX camera (Leica)
was used to record divisions at room temperature (21C). Images were
collected every 10 s using a 633/1.4 numerical aperture (NA) objective and
the LAS AF software (Leica Microsystems). Expression of the transgene was
checked in each embryo recorded to ensure that the phenotype is not due
to loss of expression.
Images to quantify the cumulative mitotic index in the G2-checkpoint
recovery assay were acquired with the same Leica microscope mentioned
above. Images were collected using a 203/1.4 NA objective and the LAS
AF software (Leica). Image processing and analysis were carried on using
Fiji software.Multiple Protein Alignments
The multiple protein alignments displayed were performed using sequences
available on UniProt: Q6PGQ7 (human), Q8BS90 (mouse), Q5M864 (rat),
Q6DJL7 (Xenopus), Q5U3U6 (fish), Q9VVR2 (Drosophila), G5ECT7 (C. elegans),
and E3LRJ7 (C. vulgaris). The sequences were aligned using PRALINE soft-
ware (http://www.ibi.vu.nl/programs/pralinewww/) with the default settings.
The sequence surrounding S137/T229 (position 134–140 on human protein)
was aligned manually using a BLOSUM62 matrix.
LC-MS/MS Analysis and Data Processing
Mass spectrometry analysis and data processing are described in the Supple-
mental Experimental Procedures.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental Procedures,
four figures, and three tables and can be found with this article online at
http://dx.doi.org/10.1016/j.celrep.2016.03.049.
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